Or83bZ4506 mutants have a lesion in the splicing donor sequence GTGAGT at the start of intron 3 that is mutated to ATGAGT. Therefore, this intron is not recognized by the splicing machinery and is included in the mature transcript. Inclusion of this intron terminates the Or83b polypeptide prematurely at residue 350.
G5408707A
G?A
Splice donor mutation.
Or83bZ4506 mutants are defective for cVA (11-cis-vaccenyl acetate) sensitivity but also have striking defects in most olfactory responses.
Or83bZ4506 mutants exhibit normal CO[[2]] responses but lack responses to general odorants.